USP Guidelines to Facilitate Supply Chain Integrity

The proposed guidelines cover five main areas: Good Importation Practices, Counterfeit Drugs and Medical Devices, Best Practices to Combat Counterfeit Drug and Medical Devices, Diversion and Theft, and Natural Disasters.

The U.S. Pharmacopeial Convention (USP) has proposed a set of recommended best practices to help ensure supply chain integrity with comprehensive public standards across the pharmaceutical industry.

The proposed guidelines cover five main areas: Good Importation Practices, Counterfeit Drugs and Medical Devices, Best Practices to Combat Counterfeit Drug and Medical Devices, Diversion and Theft, and Natural Disasters.

The new proposed standard, which is not mandatory, is contained in the USP General Chapter <1083> Good Distribution Practices—Supply Chain Integrity. The proposal is intended to serve as a central guidance outlining the essential elements of an effective strategy.